Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TLSS will have a BIG RIDE NORTH from here......buy and HOLD!
Amazon and TLSS: what a combinaton folks! and...we are at 3 cents! :)
UP is the only way here!
Amazon IS truely involved :)
You mean...last chance to get in at 3...
Grabbing all i can...no brainer
buy and hold here.....could be really spectacular in very short time
the only way for this one is: WAY UP!
website also updated with the new 8k and new telephonenumber…..company is setting up for new highs!
This company could be our big hope of a 100% coronatreatment...….100% cure so far......100% ! This coming weeks will be VERY exciting!
I agree 100%...
WOW, this looks pretty damn positive for increasing REVS for companies like TLSS.... don't see how this doesnt increase this company's profits hand over fists... The more I read on AmAZON and TLSS, especially, right here right now, I am just thoroughly amazed at how low this share price is.
Make your own decisions but don't wait too long.
GO TLSS
Wow!!!
check out the volume!
This is the time to load.....could be our famous "Lifechanger".....
Ready for an amazing ride north…….
With these incredible results this could be the best stock ever!
steady Climbing from here
CAP-1002 is an easy-to-deliver intravenous therapy that has been administered successfully to over 150 patients to date. Given its novel mechanism of action, it could be a potential game-changer in helping countless COVID-19 patients.”
we have seen profit taking today...now we are ready to go up again to new highs
Better check out the volume and the CC coming …..when it's a deal with Amazon: double from here within an hour and running to 20 dollars....
how is L2?
Six of six critically ill COVID-19 patients survived after being treated as compassionate care cases with Capricor Therapeutics Inc.’s lead candidate, an off-the-shelf cardiac cell therapy. The success prompted the FDA to review the data and approve the company’s expanded access protocol for treating as many as 20 more COVID-19 patients.
The market liked all of it, as the stock (NASDAQ:CAPR) closed 252.7% higher at $8.50 per share on April 29.
The five male and one female patients, ages 19 to 75, were treated at Cedars-Sinai Medical Center in Los Angeles with Capricor’s CAP-1002, a cardiac cell therapy made up of allogeneic cardiosphere-derived cells that exert immunomodulatory activity, according to preclinical and clinical studies. While it has an IND, CAP-1002 is not approved for any indications.
In one month, the six patients, all suffering from acute respiratory distress syndrome received I.V. infusions of 150 million allogeneic cardiosphere-derived cells. Of the five who were on ventilators, four no longer needed them within one to four days following the infusion, the company said. The fifth remains on mechanical ventilation, and the sixth patient is receiving supplemental oxygen and is listed as clinically stable. Four of the six have been discharged from Cedars-Sinai.
Laboratory biomarkers correlated with poor outcomes were measured in all six patients. Following the infusion, several patients showed improvements in biomarkers such as ferritin, absolute lymphocyte counts and C-reactive protein. No adverse events related to the administration of CAP-1002 were observed.
Capricor said CAP-1002’s immune-modulatory properties could be at the center of reining in an overstimulated immune system by modulating various inflammatory cytokines and regulating the immune response. It’s possible that the body’s overreaction to COVID-19, rather than the virus itself, can lead to death, the company added.
Los Angeles-based Capricor also plans a randomized, placebo-controlled trial for treating patients with moderate and severe COVID-19. Capricor also said it submitted an expanded access IND to investigate use of CAP-1002 in certain COVID-19 patients.
The company also expects top-line results from its interventional phase II HOPE-2 study of CAP-1002 in treating Duchenne muscular dystrophy (DMD) in mid-May. Interim data from the prespecified interim analysis showed that teens and young men with advanced DMD saw skeletal, pulmonary and cardiac improvements after receiving multiple doses of CAP-1002. The patients showed improvements in the Performance of the Upper Limb, a tool for assessing high (shoulder), mid (elbow) and distal (wrist and hand) function, with a conceptual framework reflecting the progression of weakness in ambulant and non-ambulant patients.
HOPE-2 is a randomized, double-blind, placebo-controlled trial in which participants receive CAP-1002 or a placebo in a 1-to-1 ratio. The study began in April 2018 and was set to be completed in April 2020.
Better get back in...we Will see 20 Tomorrow for sure
I think a lot higher that 20 dollars....with this news!
i miss the posts from "M" here...(not).....well, i guess he will be here tomorrow again, trying the newbies to sell…..
anyone seen Gonzi?
spectaculair results!!!!
let the seller out and new buyers in.....stronger hands coming in!
for who are you working dude? relax and enjoy the ride north!
follow the money! check out the volume here!
early profit takers out now….new buyers in....stairstepping to a dime first and quearters hereafter…..buy and HOLD and know what you own and don't let the cockroaches get your shares....
SHMP went to almost a dollar.....but this one will break to multiple dollars.....
I think SHMP-run will look very pale after our run here.....
I think we will see a parabolic move today and the rest of this week for sure….multiple dimes short time
This might not be a runner, this WILL be a BIG runner.
We will see a lot of new cockroaches on the board today and the next days / weeks.....they all just want one thing: get in cheaper and your shares.
Let's have a look here:
1. This stock was at 8 dollars, just a couple of months ago and at 16 dollars nearly a year ago.
2. It was short down, conversions, etc...
3. Now they received a 3 mio loan from the government…..3 mio!....for payroll!
4. Their revenues increased with 49%....imagine: 49% folks!
5. Their biggest client is: AMAZON!
6. With the coronavirus their revenues will increase much more in the near future
7. People do their shopping online....at AMAZON....meaning: more business!
This will not change soon!
8. The future for this company is bright, brighter than ever.
9. We are at 6 cents now…...imagine: 6 cents!
10. Cockroaches say: frontloading here......i never read funnier posts than that.
A 16 dollarstock now at 6 cents and than...frontloading.....hahahahahaha….really…..think folks!
11. I am from the Netherlands and the coronavirus is still killing here....still completely intelligent lockdown… the world will have to deal with that and shopping in stores will be a thing from the past....it's now: online shopping, and online shopping only.
So…..what will that do to our revenues here you think?....
Check out their website and read the 8k and PR from yesterday!
Check out the posts from SportyNorty and you will know what you have to do: buy and hold long!
Yesterday we were up to 0,028 and then the selling began…..drove it down to nearly 0,02.....than the big buying began up to 6 cents.....
Imagine the feelings of the sellers…..
I never saw a stock with a brighter future than this one folks….really!
check this out:
https://www.nasdaq.com/market-activity/stocks/tlss/press-releases
To strengthen the Company’s financial foundation, TLSS is implementing cost-cutting measures to reduce its annualized operating, administrative and corporate expenses by approximately $1.0 million, without any reduction in its employed drivers, the majority of which are effective immediately.
Sebastian Giordano, TLSS’ turnaround and restructuring consultant, indicated that “on the heels of last week’s announcement of a settlement agreement for outstanding merchant credit advances that will reduce and eliminate approximately $1.7 million of high-interest debt when completed, management and the Board of Directors are continuing to evaluate all opportunities to restructure the Company’s balance sheet and improve current operating results. The Company believes that these expense reductions are a significant step towards achieving that objective.”
Always do your own DD folks...i did!
Buy and HOLD!
a lot of new eyes will be on this TOTAL GEM!!!!!!
this will run for weeks now! if not months!
Let's get back to multiple dimes within weeks and dollars here after
they work for: AMAZON!!!!!!
I agree cowboy! This will have a run to dollars in no time.....all the news here could not be better…..in fact: unbelievable!
Many BIG investors will be buying from now on.....
This will become Clearly evident THIS week already…..